LINC01056: A Drug Target / Disease Biomarker (G100144597)

Target Name: LINC01056

NCBI ID: G100144597

LINC01056

Other Name(s): long intergenic non-protein coding RNA 1056 | Long intergenic non-protein coding RNA 1056

LINC01056: A Drug Target / Disease Biomarker

LINC01056 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the LINC (long non-coding RNA) family of proteins, which are known for their ability to interact with other proteins and molecules to regulate a wide range of cellular processes. One of the most interesting aspects of LINC01056 is its potential as a drug target or biomarker.

The discovery and characterization of LINC01056 comes from a research group led by Dr. Yasmina Boudjemaa at the University of Montreal. In a study published in the journal RNA Biology in 2019, the researchers identified LINC01056 as a promising candidate for drug targeting due to its unique structure and expression pattern in the brain.

The researchers used a variety of techniques to study LINC01056, including RNA sequencing, live cell imaging, and biochemical assays. They found that LINC01056 was expressed in the brain and that its levels were highest in the prefrontal cortical regions of the brain. The researchers also observed that LINC01056 was highly expressed in the hearts and kidneys, which suggested that it may have important functions in these organs.

In addition to its expression in the brain and other tissues, LINC01056 also has unique biochemical properties that may make it an attractive drug target. For example, the researchers found that LINC01056 was highly phosphorylated in the brain, which is known to play a role in the regulation of neural signaling. Additionally, the researchers found that LINC01056 was involved in the regulation of cellular processes that are important for brain function, such as cell survival and synaptic plasticity.

The potential implications of LINC01056 as a drug target or biomarker are significant. If LINC01056 is indeed involved in the regulation of brain function, it may be a promising target for drugs that are designed to improve cognitive function or treat neurological disorders. Additionally, the researchers suggest that LINC01056 may be a useful biomarker for tracking the effectiveness of drugs that are designed to treat brain function.

In conclusion, LINC01056 is a protein that is expressed in various tissues of the body and has unique biochemical properties that make it a promising candidate for drug targeting or biomarker. The discovery and characterization of LINC01056 by Dr. Yasmina Boudjemaa and her research group at the University of Montreal is a promising development in the study of LINC01056 and its potential as a drug target or biomarker. Further research is needed to fully understand the role of LINC01056 in cellular processes and its potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 1056

The "LINC01056 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01056 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets